100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
In Treatment of Bacterial infections Ofrit 50mg Syrup is an antibiotic medicine that can be used to treat many different infections caused by bacteria. It stops the growth of the bacteria causing the infection and clears the infection. Take it for as long as prescribed by the doctor and avoid skipping doses. This will make sure that all bacteria are killed and they do not become resistant.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Ofrit 50mg Syrup is an antibiotic. It interferes with the genetic material of bacteria by implanting defects in its DNA. These defects hamper the multiplication of the bacteria and affect its survival as well. Thus, it kills the infection-causing bacteria from growing further and prevents the infection from spreading without making them resistant to further treatment.
Caution Advised: Ofrit 50mg Syrup should be used with caution in patients with kidney disease. Dose adjustment of Ofrit 50mg Syrup may be needed. Doctor consultation is advised.
Caution Advised: Ofrit 50mg Syrup should be used with caution in patients with liver disease. Dose adjustment of Ofrit 50mg Syrup may be needed. Doctor consultation is advised. However, discontinue its use immediately if signs or symptoms of hepatitis like vomiting, paleness, and weakness is observed.
Head Office: A2/494, Sec-8, Rohini Delhi - 110085
World Health Organization. The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children) (04 Jan. 2021)
Garcia-Prats AJ, Draper HR, Thee S, et al. Pharmacokinetics and Safety of Ofloxacin in Children with Drug-Resistant Tuberculosis. Antimicrob Agents Chemother. 2015;59(10):6073-6079 (04 Jan. 2021)
MacDougall C. Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections. In: Brunton LL, Hilal-Dandan R, Knollmann BC (Editors). Goodman & Gilman's: The Pharmacological Basis of Therapeutics. 13th ed. New York, New York: McGraw-Hill Medical; 2018. p. 1017
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.